Dianthus Therapeutics (MGTA) Revenue & Revenue Breakdown
Dianthus Therapeutics Revenue Highlights
Latest Revenue (Y)
$314.00K
Latest Revenue (Q)
$72.00K
Dianthus Therapeutics Revenue by Period
Dianthus Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $314.00K | -82.28% |
| 2022-12-31 | $1.77M | -40.20% |
| 2021-12-31 | $2.96M | 182.19% |
| 2020-12-31 | $1.05M | -76.46% |
| 2019-12-31 | $4.46M | -46.80% |
| 2018-12-31 | $8.39M | 109.49% |
| 2017-12-31 | $4.00M | 19.96% |
| 2016-12-31 | $3.34M | 31.48% |
| 2015-12-31 | $2.54M | -41.25% |
| 2014-12-31 | $4.32M | 0.08% |
| 2013-12-31 | $4.32M | -2.03% |
| 2012-12-31 | $4.41M | - |
Dianthus Therapeutics generated $314.00K in revenue during NA 2023, up -82.28% compared to the previous quarter, and up 3.74% compared to the same period a year ago.
Dianthus Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $72.00K | - |
| 2023-12-31 | $72.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $756.00K | - |
Dianthus Therapeutics generated $72.00K in revenue during Q1 2024, up 0.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Dianthus Therapeutics Peer Comparison by Revenue
MGTA Revenue FAQ
What is Dianthus Therapeutics’s yearly revenue?
Dianthus Therapeutics's yearly revenue for 2023 was $314K, representing a decrease of -82.28% compared to 2022. The company's yearly revenue for 2022 was $1.77M, representing a decrease of -40.20% compared to 2021. MGTA's yearly revenue for 2021 was $2.96M, representing an increase of 182.19% compared to 2020.
What is Dianthus Therapeutics’s quarterly revenue?
Dianthus Therapeutics's quarterly revenue for Q1 2024 was $72K, a 0% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $72K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). MGTA's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Dianthus Therapeutics’s revenue growth rate?
Dianthus Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -89.40%, and for the last 5 years (2019-2023) was -92.96%.